As on (02 Mar 2024 | 01:40)
Back To Homepage As on (02 Mar 2024 | 01:40)
Sun Pharma receives Health Canada approval for WINLEVI Back
(19 Jun 2023)
Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries has received Health Canada's approval of WINLEVI (clascoterone cream 1%).

WINLEVI is the first and only androgen receptor inhibitor indicated for the topical treatment of acne vulgaris (acne) in patients 12 years of age and older, and the newest Health Canada-approved formulation to target the hormonal component of acne for Canadian patients in 40 years.